Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Last Updated
In the Matter of Laboratory Corporation of America Holdings, a corporation, and Orchid Cellmark Inc., a corporation
FTC Matter/File Number
111 0155
Docket Number
C-4341
Enforcement Type
Part 2 Consents

Case Summary

The Commission required laboratory testing companies Laboratory Corporation of America Holdings and Orchid Cellmark Inc. to divest a portion of Orchid's paternity testing business, to resolve the FTC complaint alleging that LabCorp's $85.4 million acquisition of Orchid would have an anticompetitive impact in the market for paternity testing services used by government agencies. Under the proposed settlement order, the portion of Orchid's U.S. paternity testing business that is focused on sales to government agencies, and related assets, will be sold to another testing company, DNA Diagnostics Center (DDC). On 2/1/2012, the FTC approved a final order.